63 /100
HIGH RISK
Score updated Jul 14, 2026

OGEN — Oragenics, Inc. Dilution Risk Tracker

Track OGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OGEN — Get alerts when the score changes →

As of July 14, 2026, Oragenics, Inc. (OGEN) has a DilutionWatch DilutionScore of 63/100, rated HIGH dilution risk. Oragenics, Inc. has a market capitalization of $2.73M, 4.51M shares outstanding, 10 institutional holders tracked. Key dilution vectors include 13.80M outstanding warrants, approximately 13 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
35
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
54%
📜 Warrant Exercise 60%
• Massive warrant overhang: 306% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split 55%
• 50-day avg $0.62 below $1 exchange minimum
🔁 Convertible Conversion 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
🔔 Track OGEN — Get forecast alerts →

💹 Market Data

Market Cap$2.73M
Shares Outstanding4.51M
Float4.41M
Cash$10.11M
Debt$56.1K
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 190.1K shares
#1 Geode Capital Management, LLC 65.1K shares
#2 Pathstone Holdings, LLC 55.0K shares
#3 Two Sigma Securities, LLC 20.3K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest775.0K
Days to Cover16.8
% of Float17.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2015
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for OGEN Shareholders

Oragenics, Inc. (OGEN) has a DilutionScore of 63/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 13.8M outstanding warrants for OGEN. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: OGEN has approximately 13 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for OGEN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for OGEN alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track OGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for OGEN
📊 OGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OGEN Signal Convergence & Dark Pool Activity — StonkWhisper 📄 OGEN Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.